Compare · CPUH vs ORIA
CPUH vs ORIA
Side-by-side comparison of Compute Health Acquisition Corp. (CPUH) and Orion Biotech Opportunities Corp. (ORIA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CPUH and ORIA operate in Blank Checks (Finance), so they compete in similar markets.
- CPUH is the larger of the two at $1.05B, about 4.3x ORIA ($242.0M).
Compute Health Acquisition Corp.
Compute Health Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in Wilmington, Delaware.
Orion Biotech Opportunities Corp.
Orion Biotech Opportunities Corp., a blank check company, intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities. The company was founded in 2021 and is based in New York, New York.
Latest CPUH
- SEC Form 15-12G filed by Compute Health Acquisition Corp.
- SEC Form 4: Compute Health Sponsor Llc was granted 2,088,327 shares and returned 2,088,327 shares to the company (Amendment)
- SEC Form 4: Harsh Michael was granted 21,120 shares and returned 31,120 shares to the company, closing all direct ownership in the company
- SEC Form 4: Watanabe Gwendolyn A was granted 21,120 shares and returned 21,120 shares to the company
- SEC Form 25-NSE filed by Compute Health Acquisition Corp.
- Allurion Debuts as a Publicly Traded Company on the NYSE
- SEC Form DEFA14A filed by Compute Health Acquisition Corp.
- Compute Health Acquisition Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Compute Health Acquisition Corp. Stockholders Approve Business Combination with Allurion
- SEC Form 425 filed by Compute Health Acquisition Corp.
Latest ORIA
- SEC Form SC 13G/A filed by Orion Biotech Opportunities Corp. (Amendment)
- SEC Form 4 filed by Collins James J.
- SEC Form 4 filed by Broder Samuel
- SEC Form 4 filed by Orion Sponsor Holdings, Llc
- SEC Form 4 filed by Rodriguez Louisa
- SEC Form 15-12G filed by Orion Biotech Opportunities Corp.
- SEC Form 25 filed by Orion Biotech Opportunities Corp.
- Orion Biotech Opportunities Says Will Redeem Public Share, Will Not Consummate Initial Business Combination
- Orion Biotech Opportunities Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 10-K filed by Orion Biotech Opportunities Corp.